Antisense Elements (Genetics)
"Antisense Elements (Genetics)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nucleic acids which hybridize to complementary sequences in other target nucleic acids causing the function of the latter to be affected.
| Descriptor ID |
D016375
|
| MeSH Number(s) |
D13.150 D13.444.600.150 D27.720.470.530.600.150
|
| Concept/Terms |
Antisense Probes- Antisense Probes
- Probes, Antisense
- Anti-Sense Probes
- Anti Sense Probes
- Probes, Anti-Sense
|
Below are MeSH descriptors whose meaning is more general than "Antisense Elements (Genetics)".
Below are MeSH descriptors whose meaning is more specific than "Antisense Elements (Genetics)".
This graph shows the total number of publications written about "Antisense Elements (Genetics)" by people in this website by year, and whether "Antisense Elements (Genetics)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antisense Elements (Genetics)" by people in Profiles.
-
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019 07; 38(28):5700-5724.
-
Regulation of Antisense Transcription by NuA4 Histone Acetyltransferase and Other Chromatin Regulatory Factors. Mol Cell Biol. 2016 Jan 11; 36(6):992-1006.
-
Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol Cell Biol. 2010 Sep; 30(18):4435-51.
-
Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer. Gastroenterology. 2002 Sep; 123(3):817-26.
-
Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression. Cancer Lett. 2001 Dec 28; 174(2):151-8.
-
Expression of Ca(2+)/calmodulin-dependent protein kinase IV (caMKIV) messenger RNA during murine embryogenesis. Cell Growth Differ. 2001 Jul; 12(7):351-61.
-
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF. Br J Cancer. 2001 May 04; 84(9):1252-7.
-
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor. Clin Cancer Res. 2000 Nov; 6(11):4422-31.
-
Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion. J Surg Res. 1999 Apr; 82(2):331-8.
-
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology. 1998 Aug; 115(2):287-96.